NDI NATIONAL DRUG INDEX Trademark

Trademark Overview

On Tuesday, September 16, 2014, a trademark application was filed for NDI NATIONAL DRUG INDEX with the United States Patent and Trademark Office. The USPTO has given the NDI NATIONAL DRUG INDEX trademark a serial number of 86396857. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Friday, April 8, 2022. This trademark is owned by TRUVERIS, INC.. The NDI NATIONAL DRUG INDEX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Conducting business research, compiling and analyzing statistics, data and other sources of information for business purposes and conducting analysis of market research data and statistics all with respect to pharmaceutical drug industry pricing; conducting business research, compiling and analyzing statistics, data and other sources of information for business purposes and conducting analysis of market research data and statistics all with respect to periodic fluctuations in drug prices of pharmaceutical manufacturers and pharmaceutical drug spending of patients as an index of pharmaceutical industry growth
ndi national drug index

General Information

Serial Number86396857
Word MarkNDI NATIONAL DRUG INDEX
Filing DateTuesday, September 16, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateFriday, April 8, 2022
Registration Number4819554
Registration DateTuesday, September 22, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2014

Trademark Statements

Goods and ServicesConducting business research, compiling and analyzing statistics, data and other sources of information for business purposes and conducting analysis of market research data and statistics all with respect to pharmaceutical drug industry pricing; conducting business research, compiling and analyzing statistics, data and other sources of information for business purposes and conducting analysis of market research data and statistics all with respect to periodic fluctuations in drug prices of pharmaceutical manufacturers and pharmaceutical drug spending of patients as an index of pharmaceutical industry growth
NOT AVAILABLE"NATIONAL DRUG INDEX"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 24, 2014
Primary Code035
First Use Anywhere DateFriday, June 26, 2015
First Use In Commerce DateFriday, June 26, 2015

Trademark Owner History

Party NameTRUVERIS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameTRUVERIS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameTRUVERIS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Friday, September 26, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, September 19, 2014NEW APPLICATION ENTERED
Wednesday, September 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 26, 2014ASSIGNED TO EXAMINER
Friday, September 26, 2014EXAMINERS AMENDMENT E-MAILED
Friday, September 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 26, 2014EXAMINER'S AMENDMENT ENTERED
Friday, October 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 3, 2014ASSIGNED TO LIE
Monday, November 3, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 9, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 9, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 9, 2015TEAS STATEMENT OF USE RECEIVED
Monday, February 9, 2015USE AMENDMENT FILED
Monday, March 16, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 23, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 16, 2015SU - NON-FINAL ACTION - WRITTEN
Thursday, April 16, 2015NON-FINAL ACTION E-MAILED
Thursday, April 16, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 19, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 20, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, December 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 3, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 3, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, September 16, 2021TEAS SECTION 8 RECEIVED
Tuesday, March 29, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 8, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, April 8, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, September 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

index drug national pharmaceutical statistics conducting research business data industry respect analysis